Literature DB >> 21530293

Long-term patency of the stapled bovine pericardial conduit for replacement of the superior vena cava.

Anna Maria Ciccone1, Federico Venuta, Antonio D'Andrilli, Claudio Andreetti, Mohsen Ibrahim, Tiziano De Giacomo, Domenico Massullo, Erino Angelo Rendina.   

Abstract

OBJECTIVE: Artificial prosthesis of the superior vena cava (SVC) may occlude with time. For this reason, we proposed in 2003 the use of a biological material (bovine pericardium) and devised an original technique to construct the prosthetic conduit. We hereby report the long-term results in 15 patients.
METHODS: The SVC prosthetic conduit is realized by wrapping a bovine pericardial leaflet around a 5 or 10 cm(3) syringe and stapling it on the side by a 60-80 linear stapler. This procedure is carried out intra-operatively after the size of the patient's SVC has been ascertained; the conduit is then cut to the appropriate length. We have employed this technique in 15 patients with lung (eight) or mediastinal (seven) tumors; after a minimum follow-up of 1 year, all patients underwent computed tomographic-volume rendering (CT-VR) studies of the SVC.
RESULTS: Technically, the stapled pericardial conduit has several advantages: (1) it is simple and expeditious; (2) it allows an even and regular suture line, which cannot be achieved by hand suturing; (3)'one size fits all': with one single pericardial leaflet, conduits of all sizes can be realized; this is important for an operation which is performed only few times per year; (4) patency is granted by the intrinsic rigidity of the pericardium and staple line, without the need for any reinforcement; (5) different calibers at the two extremities can be obtained by simply placing the stapler obliquely; and (6) the staple line is excellent for the orientation of the conduit while suturing. In our patients, SVC clamping time ranged between 18 and 50 min (mean 29 min); one patient needed cardiopulmonary bypass. Intra-operative anticoagulation (1.500-2.500 units of heparin) was continued postoperatively subcutaneously for 7 days and then shifted to oral anticoagulation for 6 months. One patient died postoperatively of heart failure (mortality 6%). One to 5 years after surgery, CT-VR showed full patency of the pericardial conduit, no clots or thrombus formation, and absence of collateral venous circulation in all 14 patients. One- and 5-year survival was 93% and 73%, respectively (Kaplan-Meier).
CONCLUSIONS: The stapled bovine pericardial conduit is a simple, expeditious, and economic solution to SVC replacement, and offers reliable long-term patency without permanent anticoagulation.
Copyright © 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21530293     DOI: 10.1016/j.ejcts.2011.03.008

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  9 in total

1.  The use of biological grafts for reconstruction of the inferior vena cava is a safe and valid alternative: results in 32 patients in a single institution.

Authors:  Carlo Pulitanó; Michael Crawford; Phong Ho; James Gallagher; David Joseph; Michael Stephen; Charbel Sandroussi
Journal:  HPB (Oxford)       Date:  2013-01-18       Impact factor: 3.647

2.  Initial extended resection or neoadjuvant therapy for T4 non-small cell lung cancer-What is the evidence?

Authors:  Ilkka Ilonen; David R Jones
Journal:  Shanghai Chest       Date:  2018-10-11

3.  Extracorporeal membrane oxygenation (ECMO) assisted mediastinal tumor resection and superior vena cava replacement are safe and feasible.

Authors:  Shixin Zhang; Deli Tan; Wei Wu; Bo He; Tao Jing; Meng Tang; Tao Wu; Hongxiang Liu; Ming Zhang; Ni Zhou; Lingfeng Tang; Qiao Chen; Jinghua Tang; Mei Xia; Aihong Huang; Yi Liao; Yang Qiu; Haidong Wang
Journal:  Thorac Cancer       Date:  2019-07-12       Impact factor: 3.500

Review 4.  Parenchymal Sparing Surgery for Lung Cancer: Focus on Pulmonary Artery Reconstruction.

Authors:  Cecilia Menna; Erino Angelo Rendina; Antonio D'Andrilli
Journal:  Cancers (Basel)       Date:  2022-09-30       Impact factor: 6.575

5.  Superior vena cava resection and reconstruction in mediastinal tumors and benign diseases.

Authors:  Erkan Kaba; Berker Özkan; Mehmet Oğuzhan Özyurtkan; Kemal Ayalp; Alper Toker
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-01-09       Impact factor: 0.332

6.  Superior vena cava replacement combined with venovenous shunt for lung cancer and thymoma: a case series.

Authors:  Wei Dai; Jifu Dong; Hongwei Zhang; Xiaojun Yang; Qiang Li
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

7.  Inferior Vena Cava Reconstruction with Tubularized Bovine Pericardium.

Authors:  J Hunter Mehaffey; Robert Jason Perry; Nicolas H Pope; Gilbert R Upchurch
Journal:  J Vasc Surg Cases       Date:  2016-03-01

8.  Thoracic tumor resection combined with SVC replacement using autologous pericardium.

Authors:  Sicong Jiang; Hao Hu; Changying Guo; Feng Jiang; Xi Liu; Lang Tang; Jianjun Tang; Xiaoliang Cheng
Journal:  World J Surg Oncol       Date:  2019-12-21       Impact factor: 2.754

9.  Superior vena cava graft infection in thoracic surgery: a retrospective study of the French EPITHOR database.

Authors:  Laura Filaire; Olaf Mercier; Agathe Seguin-Givelet; Olivier Tiffet; Pierre Emmanuel Falcoz; Pierre Mordant; Pierre-Yves Brichon; Philippe Lacoste; Axel Aubert; Pascal Thomas; Françoise Le Pimpec-Barthes; Ioana Molnar; Magali Vidal; Marc Filaire; Géraud Galvaing
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-02-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.